PureBiotic Air Provide Virginia State University Results on Biofilm & Pathogens

Manganese X Subsidiary and JV Partner PureBiotic Air Provide Virginia State University Results on Biofilm & Pathogens Including COVID-19

Montréal, Québec, Canada, March 16th, 2021, Manganese X Energy Corp. (TSXV: MN) (FSE: 9SC2) (OTC: MNXXF) (“Manganese X”, “MN” or the “Company”) is pleased to announce that its wholly owned subsidiary, Disruptive Battery Corp. (DBC) in conjunction with its US JV Partner, PureBiotic Air Inc.(PureBiotic), has received positive preliminary results from its ongoing research study with Virginia State University (VSU). The results include the successful production of the biofilm required to advance its research and testing of the PureBiotic HVAC Delivery System for the mitigation of COVID-19 and other contaminants.                                                                                                 

CEO Martin Kepman stated “The Team is pleased with the progress of the production of biofilm on various type surfaces that are found in all types of facilities and homes. This initial step should accelerate the required research and testing to document the ability of specific PureBiotics AIR Mist Solutions to deconstruct and remove these biofilm structures. It will create hostile environments that will reduce the risk of pathogenic bacteria and viruses, including the current pathogen of concern around the world, SARS-CoV-2 virus that is causing the COVID-19 pandemic. It should also be noted that biofilm is calculated by the Centers for Disease Control and Prevention (CDC) to be responsible for some 80% of all infections and it is found on almost all surfaces, including your skin. The company’s ultimate goal is to create a product for FDA certification.”

STUDY SUMMARY: This initial portion of the study covers the formation of biofilms on different surface materials, specifically by pathogenic bacteria, as per the protocols formulated by the VSU Research Team in conjunction with JV Partner and head of R&D at PureBiotic, Lino G. Morris.  This will meet the specifications required to document the ability to grow the mandatory required biofilm needed on a wide variety of test surfaces.

The study will then further document the ability of specific PureBiotics AIR Mist Solutions to deconstruct and remove these biofilm structures down to the bare microscopic level.  This means the removal of any protective cover creating hostile environments in order to reduce the risk of pathogenic bacteria and viruses, including the COVID-19 pathogen. Testing data on these formulations for a wide range of Hospital Acquired Infections (as well as in a wide variety of both food production and food processing facilities) has shown a major reduction in overall infections when compared with standard hospital disinfectants.  There has also been an additional benefit in the reduction of odours in all of the facilities tested.

Various HVAC systems will also be tested, as the final goal of these studies, to determine whether all biofilm growth can be removed.  In addition to the COVID-19 pathogens, there is a  large range of bacterial, viral, mold and mildew growths and the significant concern of allergens, all contained inside HVAC systems.

It should be noted that bacteria and viruses are commonly collected and especially found growing in the cooling towers of buildings, and also contaminating all of the various transportation sections/units of HVAC systems (such as all the various ducts works and air vents).  There are additional special problems in the cooling towers because of the affinity of biofilm for binding of the minerals in the water used in all of these systems for cooling.   Further, eliminating biofilm from the coils of the HVAC and associated systems will provide far healthier environments and large savings in power consumption.


In previous tests, the results indicated a significant ability of the PureBiotic AIR Solutions to provide probable deconstruction of biofilm.  This came from the original indirect testing in which the PureBiotic AIR Solutions were tested on contaminants in locations such a hospital facility where many years of biofilm had built-up on surfaces.  When used and observed within a time period of three weeks, there were significant test results in which the levels of pathogens were significantly reduced on the floor and surrounding areas of a hospital facility regardless of soiling, internal spills and “accidents” that occurred.  This also included testing with a range of outside visitors walking the areas.  The regrowth of pathogens seriously declined and the areas treated were visibly cleaner and grout lines had lightened, and by the end of the third week, the testing for contamination showed dozens of clear plates from all of the areas tested.

The initial conclusion, since all testing to date has been positive, is that as the VSU study progresses, it is anticipated that the results should continue to provide additional proof of the benefits of this breakthrough in controlling the microscopic environment. It does so in a safe, easy, and low labor methodology. More detailed results will be provided as they are available.

The company is not making any express or implied claim that it has developed a COVID-19 air management solution at this time.

About Manganese X Energy

The Company’s mission is to acquire and advance high potential manganese mining prospects located in North America with the intent of supplying value added materials to the lithium ion battery and other alternative energy industries. In addition, Manganese X Energy is striving to achieve new methodologies emanating from technologies for environmentally geographically ethical and friendly green/zero emissions, while processing manganese at a lower competitive cost.

For more information, visit the website at www.manganesexenergycorp.com.


Martin Kepman
CEO and Director

Cautionary Notes: General and Forward-Looking Statements

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release is not an offer to sell, or a solicitation of an offer to buy or sell, any securities of the Company and may not be relied upon in connection with the purchase or sale of any such security.

This news release contains “forward-looking information” within the meaning of Canadian securities legislation. The forward-looking information contained in this news release represents the expectations of the Company as of the date of this news release and, accordingly, is subject to change after such date. Forward-looking information includes information including statements with respect to the future exploration performance of the Company. Forward-looking information is based on, among other things, opinions, assumptions, estimates and analyses that, while considered reasonable by the Company at the date the forward-looking information is provided, are inherently subject to significant risks, uncertainties, contingencies and other factors that may cause actual results and events to be materially different from those expressed or implied by the forward-looking information. The risks, uncertainties, contingencies and other factors that may cause actual results to differ materially from those expressed or implied by the forward-looking information may include, but are not limited to (i) adverse market conditions; (ii) risks inherent in the mining industry in general; (iii) the Exchange not approving the Offering; or (iv) risks generally associated with the Company’s business, as described in the Company’s public filings on SEDAR, which readers are encouraged to review in detail prior to any transaction involving the securities of the Company. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company does not intend to update these forward-looking statements. Readers should not place undue importance on forward-looking information and should not rely upon this information as of any other date.